EdgePoint Investment Group’s Twist Bioscience TWST Stock Holding History

EdgePoint Investment Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259M	Sell	2,521,635 -2,860,886	-53%	-$186M	1.96%	18
2026 Q1	$256M	Buy	5,382,521 +4,530	+0.1%	+$203K	2.05%	18
2025 Q4	$171M	Buy	5,377,991 +1,295,672	+32%	+$40.4M	1.4%	17
2025 Q3	$115M	Buy	4,082,319 +1,696,377	+71%	+$51.4M	0.86%	22
2025 Q2	$87.8M	Buy	2,385,942 +1,272,732	+114%	+$44M	0.66%	24
2025 Q1	$43.7M	Buy	+1,113,210	New	+$50.1M	0.35%	30

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

EdgePoint Investment Group's TWST Position: Q2 2026 in Review

EdgePoint Investment Group reduced its Twist Bioscience (TWST) stake by 53% in Q2 2026, selling an estimated $186M and leaving 2,521,635 shares worth $259M. The position accounts for 1.96% of the portfolio, ranked #18.

EdgePoint Investment Group first reported a position in TWST in Q1 2025 and has held it in 6 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

EdgePoint Investment Group held 2,521,635 shares of Twist Bioscience worth $259M as of Q2 2026.
EdgePoint Investment Group sold 2,860,886 Twist Bioscience shares in Q2 2026, an estimated $186M.
Twist Bioscience made up 1.96% of EdgePoint Investment Group's portfolio in Q2 2026, its #18 holding.
EdgePoint Investment Group first reported a position in Twist Bioscience in Q1 2025 and has held it in 6 quarters since.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on EdgePoint Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.